Quest Diagnostics
- DGX
- NYSE
- Other Services
- Latest 60.69
- Currency US$
- Change 0.81
- Percent Change 1.353 %
- Volume 972,471
- Fri May 17, 2013 4:05 PM EDT NYSE data delayed 15 minutes.
The Globe and Mail
- Open 59.86
- Previous Close 59.88
- High 60.79
- Low 59.79
- Bidx0 --
- Askx0 61.97
- 52-week High 10/08 64.87
- 52-week Low 06/06 53.25
- Beta 0.823
- Market Cap 9,602.37M
- EPS 4.25
- P/E 14.28
- Forward P/E 12.488
- PEG 1.27
- Annual Dividend 1.20
- Yield 1.977
News
- Quest Diagnostics Acquires Concentra's Laboratory Business, Enters into Exclusive Services Agreement
- Quest Diagnostics to Speak at the Bank of America Merrill Lynch 2013 Health Care Conference
- Quest Diagnostics Reports First Quarter 2013 Financial Results
- Quest Diagnostics to Acquire Lab-Related Clinical Outreach Operations of Dignity Health in California and Nevada
- Quest Diagnostics Names Jim Davis, Senior Vice President, Diagnostic Solutions
Financials & Calendars
- Sales $7,318,600,000
- Earnings $532,430,000
- Return on Equity 12.66%
- Cash Flow --
- Cash $133,600,000
- Current Ratio 1.21
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $9,306,160,000
- Liabilities $5,078,810,000
- Liabilities-to-Equity Ratio 1.20
Price Ratios
- Price to Sales 1.31
- Price to Book 2.27
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | Apr 17 | $1.04 | Jul 18 | $1.10 |
| Surprises | Apr 17 | -14.42% | n/a | n/a |
| Dividends | Mar 28 | $0.30 | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended May 18, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
Officers
- Daniel C. Stanzione Chairman of the Board
- Stephen H. Rusckowski President and Chief Executive
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Head Office
3 GIRALDA FARMSMADISON, NJ
07940
Phone: 9735202700
Fax: (201)-4624169
Ideas & Discussion
Live Discussion of DGX on StockTwits